Analysis on epidemiological characteristics of influenza in Qingdao City, 2018-2022
-
摘要:
目的 分析青岛市2018—2022年流行性感冒(简称流感)样病例的流行病学特征和病原学特征,总结青岛市流感的流行规律,为流感的防控提供科学依据。 方法 采用描述流行病学方法对2018—2022年青岛市流感流行特征进行分析,采用Excel 2019软件和SPSS 21.0软件对数据进行整理和分析。 结果 2018—2022年青岛市共报告流感样病例(influenza-like illness, ILI)292 912例,门急诊病例3 427 961例,年均ILI占比为8.54%。不同年度ILI%的差异有统计学意义(χ2=10 565.926, P<0.001)。ILI中0~<5岁年龄组占比最高(49.22%),15~<25岁年龄组占比最低(5.80%)。流感流行有季节性,发病高峰期主要在冬春季,2021年后出现夏季波动。2018—2022年共对11 437份样本进行核酸检测,其中1 206份样本结果为阳性,阳性检出率为10.54%。其中,5~<15岁年龄组流感病毒阳性检出率最高(13.73%),不同年龄组流感病毒阳性检出率差异有统计学意义(χ2=60.599, P<0.001)。青岛市流感流行毒株主要为季节性H3N2(简称季节性H3)、新甲型H1N1(简称新甲H1)和乙型流感病毒Victoria系(简称Victoria),每年优势株存在差异。 结论 根据青岛市流感流行状况,在冬春季流感流行季前做好监测预警等防控措施,同时还需加强青岛市夏季流感的监测,及时调整流感防控策略。 Abstract:Objective To analyze the epidemiological and etiological characteristics of influenza in Qingdao City from 2018 to 2022 and to summarize the epidemic patterns. The findings will provide a scientific basis for the prevention and control of influenza. Methods Descriptive epidemiological methods were used to analyze the epidemiological characteristics of influenza in Qingdao City from 2018 to 2022. Excel 2019 software and SPSS 21.0 software were utilized for organizing and analyzing the data. Results From 2018 to 2022, a total of 292 912 influenza-like illness (ILI) cases were reported in Qingdao City, and the average ILI% was 8.54%. There was a statistically significant difference in ILI% between years (χ2=10 565.926, P<0.001). The proportion of ILI in the 0-<5 age group was the highest (49.22%), while the proportion in the 15-<25 age group was the lowest (5.80%). The influenza epidemic exhibits high seasonality, with the peak occurring in winter and spring, and fluctuating in summer after 2021. A total of 11 437 swab samples were tested, of which 1 206 samples tested positive for nucleic acid, resulting in a positive rate of 10.54%. The age group of 5-14 years had the highest positive rate of influenza virus (13.73%), followed by the 25-<60 age group (10.96%). The positive rate of the influenza virus varied significantly among different age groups (χ2=60.599, P<0.001). In Qingdao City, the predominant influenza strains included seasonal H3, new A H1 and B Victoria lineage viruses, with the dominant strains varying from year to year. Conclusions Based on the influenza epidemic situation in Qingdao City, it is recommended to implement prevention and control measures, such as surveillance and early warning, before the winter and spring seasons. Meanwhile, surveillance of influenza during the summer should be intensified, and prevention and control strategies should be promptly adjusted. -
Key words:
- Influenza /
- Epidemiological characteristics /
- Pathogen monitoring
-
表 1 2018—2022年青岛市流感样病例年龄分布
Table 1. Age distribution of influenza-like illness in Qingdao City from 2018 to 2022
年度
YearILI例数
Number of ILI门急诊病例总数
Number of outpatient and emergency casesILI百分比/%
Proportion of ILI/%年龄组/岁 ① Age group/years ① 0~<5 5~<15 15~<25 25~<60 ≥60 2018 78 717 717 850 10.97 51 399(65.30) 23 557(29.93) 809(1.03) 1 829(2.32) 1 123(1.42) 2019 55 051 708 269 7.77 28 947(52.58) 21 768(39.54) 1 027(1.87) 1 958(3.56) 1 351(2.45) 2020 34 059 442 463 7.70 13 603(39.94) 8 844(25.97) 3 118(9.15) 5 171(15.18) 3 323(9.76) 2021 61 963 902 965 6.86 27 568(44.49) 18 508(29.87) 4 700(7.59) 6 370(10.28) 4 817(7.77) 2022 63 122 656 414 9.62 22 643(35.87) 15 774(24.99) 7 336(11.62) 10 466(16.58) 6 903(10.94) 合计Total 292 912 3 427 961 8.54 144 160(49.22) 88 451(30.20) 16 990(5.80) 25 794(8.80) 17 517(5.98) 注:ILI, 流感样病例。
①以人数(占比/%)表示。
Note: ILI, influenza-like illness.
① Number of people (proportion/%).表 2 2018—2022年青岛市流感病毒阳性检出率及分型分布
Table 2. Positive detection rate and different types of influenza viruses in Qingdao City from 2018 to 2022
变量
Variable标本数
Number of samples阳性数
Number of positive samples阳性率/%
Positive rate/%流感分型 ① Influenza viruses subtype ① 季节性H3N2
Seasonal H3N2新甲型H1N1
New A H1N1Yamagata Victoria 年份Year 2018 1 937 249 12.85 5(2.01) 157(63.05) 86(34.54) 1(0.40) 2019 1 984 339 17.09 113(33.33) 156(46.02) 0(0) 70(20.65) 2020 3 208 157 4.89 107(68.15) 6(3.82) 0(0) 44(28.03) 2021 1 943 106 5.46 0(0) 0(0) 0(0) 106(100.00) 2022 2 365 355 15.01 151(42.54) 0(0) 0(0) 204(57.46) 年龄组/岁Age group/years 0~<5 4 385 399 9.10 102(25.56) 170(42.61) 36(9.02) 91(22.81) 5~<15 3 118 428 13.73 138(32.24) 89(20.79) 23(5.38) 178(41.59) 15~<25 1 154 102 8.84 41(40.20) 8(7.84) 8(7.84) 45(44.12) 25~<60 2 262 248 10.96 87(35.08) 40(16.13) 14(5.64) 107(43.15) ≥60 518 29 5.60 8(27.59) 12(41.38) 5(17.24) 4(13.79) 合计Total 11 437 1 206 10.54 376(31.18) 319(21.45) 86(7.13) 425(35.24) 季节Seasons 春季(3—5月) Spring (March to May) 2 192 153 6.98 33(21.57) 34(22.22) 3(1.96) 83(54.25) 夏季(6—8月) Summer (June to August) 1 203 77 6.40 76(98.70) 0(0) 0(0) 1(1.30) 秋季(9—11月) Autumn (September to November) 4 038 110 2.72 67(60.91) 4(3.64) 0(0) 39(35.45) 冬季(12月—次年2月) Winter (December to next February) 4 074 679 16.67 195(28.72) 183(26.95) 0(0) 301(44.33) 合计Total 11 507 1 019 8.86 371(36.41) 221(21.69) 3(0.29) 424(41.61) 注:Yamagata,乙型流感病毒Yamagata系;Victoria,乙型流感病毒Victoria系。
①以人数(占比/%)表示。
Note: Yamagata, influenza B virus Yamagata lineage; Victoria, influenza B virus Victoria lineage.
① Number of people (proportion/%). -
[1] Krammer F, Smith GJD, Fouchier RAM, et al. Influenza[J]. Nat Rev Dis Primers, 2018, 4: 3. DOI: 10.1038/s41572-018-0002-y. [2] Kuszewski K, Brydak L. The epidemiology and history of influenza[J]. Biomed Pharmacother, 2000, 54(4): 188-195. DOI: 10.1016/S0753-3322(00)89025-3. [3] 中国疾病预防控制中心. 中国流感疫苗预防接种技术指南(2022-2023)[J]. 中国病毒病杂志, 2023, 13(1): 1-19. DOI: 10.16505/j.2095-0136.2023.0020.Control CCFD, Prevention. Technical guidelines for seasonal influenza vaccination in China, 2022-2023[J]. Chin J Viral Dis, 2023, 13(1): 1-19. DOI: 10.16505/j.2095-0136.2023.0020. [4] 吴洁, 刘丽红, 邹惠英, 等. 流感监测网络现况及展望[J]. 现代预防医学, 2016, 43(10): 1880-1883. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201610046.htmWu J, Liu LH, Zou HY, et al. The status and Outlook of Influenza surveillance network system[J]. Modern Preventive Medcine, 2016, 43(10): 1880-1883. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201610046.htm [5] 姬莉莉, 喻金玉, 毛玉梅, 等. 2014-2022年北京市怀柔区流感样病例流行情况及病原学监测分析[J]. 疾病监测, 2023, 38(7): 781-785. DOI: 10.3784/jbjc.202303030081.Ji LL, Yu JY, Mao YM, et al. Epidemiological and etiological surveillance for influenza-like illness in Huairou district, Beijing, 2014-2022[J]. Dis Surveill, 2023, 38(7): 781-785. DOI: 10.3784/jbjc.202303030081. [6] 文艳, 陈华, 刘世安, 等. 四川省绵阳市2019-2021年流行性感冒流行病学特征分析[J]. 中国热带医学, 2023, 23(1): 64-69. DOI: 10.13604/j.cnki.46-1064/r.2023.01.12.Wen Y, Chen H, Liu SA, et al. Epidemiological characteristics of influenza in Mianyang, Sichuan, 2019-2021[J]. Chin Tropical Medcine, 2023, 23(1): 64-69. DOI: 10.13604/j.cnki.46-1064/r.2023.01.12. [7] 王磊, 郭旭, 许振华, 等. 2018-2021年保定市流行性感冒流行特征及监测质量评价[J]. 职业与健康, 2022, 38(16): 2231-2234. DOI: 10.13329/j.cnki.zyyjk.2022.0470.Wang L, Guo X, Xu ZH, et al. Epidemic characteristic of influenza in Baoding City from 2018-2021 and evaluation of monitoring quality[J]. Occup Health, 2022, 38(16): 2231-2234. DOI: 10.13329/j.cnki.zyyjk.2022.0470. [8] 郑霄雁, 陈敏红, 徐幽琼, 等. 福州市新冠肺炎疫情防控前后的流行性感冒流行特征[J]. 热带医学杂志, 2022, 22(8): 1153-1157. DOI: 10.3969/j.issn.1672-3619.2022.08.028.Zheng XY, Chen MH, Xu YQ, et al. The epidemiological analysis of influenza before and after the outbreak of COVID-19 in Fuzhou[J]. J Trop Med, 2022, 22(8): 1153-1157. DOI: 10.3969/j.issn.1672-3619.2022.08.028. [9] 刘艳, 金玫华, 沈建勇, 等. 新型冠状病毒肺炎疫情防控措施对湖州市流行性感冒流行特征的影响[J]. 预防医学, 2021, 33(4): 332-336. DOI: 10.19485/j.cnki.issn2096-5087.2021.04.002.Liu Y, Jin MH, Shen JY, et al. The influence of COVID-19 prevention and control measures on the epidemic of influenza in Huzhou[J]. Prev Med, 2021, 33(4): 332-336. DOI: 10.19485/j.cnki.issn2096-5087.2021.04.002. [10] 姜晨彦, 崔鹏, 潘浩, 等. 新型冠状病毒肺炎防控措施对流感传播的影响[J]. 上海预防医学, 2021, 33(12): 1109-1112, 1175. DOI: 10.19428/j.cnki.sjpm.2021.20926.Jiang CY, Cui P, Pan H, et al. Impact of COVID-19 control measures on the spread of influenza[J]. Shanghai Journal of Preventive Medicine, 2021, 33(12): 1109-1112, 1175. DOI: 10.19428/j.cnki.sjpm.2021.20926. [11] Aiello AE, Murray GF, Perez V, et al. Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial[J]. J Infect Dis, 2010, 201(4): 491-498. DOI: 10.1086/650396. [12] Soo RJJ, Chiew CJ, Ma S, et al. Decreased influenza incidence under COVID-19 control measures, Singapore[J]. Emerg Infect Dis, 2020, 26(8): 1933-1935. DOI: 10.3201/eid2608.201229. [13] 时慧, 杜学婷, 温行. 2019-2020年丹东市流行性感冒监测结果分析[J]. 社区医学杂志, 2021, 19(11): 651-654. DOI: 10.19790/j.cnki.JCM.2021.11.01.Shi H, Du XT, Wen X. Analysis of monitoring results influenza epidemic in Dandong from 2019 to 2020[J]. J Community Med, 2021, 19(11): 651-654. DOI: 10.19790/j.cnki.JCM.2021.11.01. [14] Cohen R, Pettoello-Mantovani M, Somekh E, et al. European pediatric societies call for an implementation of regular vaccination programs to contrast the immunity debt associated to coronavirus disease-2019 pandemic in children[J]. J Pediatr, 2022, 242: 260-261. e3. DOI: 10.1016/j.jpeds.2021.11.061. [15] Feng LZ, Zhang T, Wang Q, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States[J]. Nat Commun, 2021, 12(1): 3249. DOI: 10.1038/s41467-021-23440-1. [16] 刘慧慧, 黄小燕, 吕娟, 等. 新型冠状病毒肺炎疫情期间的流感病毒监测结果分析[J]. 安徽预防医学杂志, 2021, 27(3): 235-237. DOI: 10.19837/j.cnki.ahyf.2021.03.016.Liu HH, Huang XY, Lv J, et al. Surveillance of influenza viruses during COVID-19 outbreak[J]. Anhui J Prev Med, 2021, 27(3): 235-237. DOI: 10.19837/j.cnki.ahyf.2021.03.016. [17] 方森洲, 洪峰, 李世军, 等. 新冠疫情防控下的贵州省流感流行特征变化[J]. 现代预防医学, 2022, 49(2): 196-201. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202202002.htmFang SZ, Hong F, Li SJ, et al. Changes in the epidemic characteristics of influenza under the prevention and control measures for COVID-19 in Guizhou Province[J]. Modern Preventive Medcine, 2022, 49(2): 196-201. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF202202002.htm [18] 丁小满, 刘慧, 亓娜, 等. 2016年4月-2022年3月深圳市和济南市流感病原学监测及流行特征[J]. 山东大学学报(医学版), 2023, 61(5): 96-101, 118. DOI: 10.6040/j.issn.1671-7554.0.2022.1036.Ding XM, Liu H, Qi N, et al. Pathogenic detection and epidemic characteristics of Influenza in Shenzhen and Jinan from April 2016 to March 2022[J]. J Shandong Univ Health Sci, 2023, 61(5): 96-101, 118. DOI: 10.6040/j.issn.1671-7554.0.2022.1036. [19] 金丽娜, 史凤琳, 赵燕航, 等. 2016-2020年度北京市海淀区流行性感冒流行特征分析[J]. 首都公共卫生, 2021, 15(4): 224-227. DOI: 10.16760/j.cnki.sdggws.2021.04.012.Jin LN, Shi FL, Zhao YH, et al. Analysis of epidemiological characteristics of influenza in Haidian district of Beijing, 2016-2020[J]. Capital Journal of Public Health, 2021, 15(4): 224-227. DOI: 10.16760/j.cnki.sdggws.2021.04.012. [20] 吴迪, 刘艳慧, 曹蓝, 等. 广州市2017-2020年流感流行特征分析[J]. 中国预防医学杂志, 2022, 23(1): 37-43. DOI: 10.16506/j.1009-6639.2022.01.007.Wu D, Liu YH, Cao L, et al. Epidemiological characteristics of influenza in Guangzhou from 2017 to 2020[J]. Chin Prev Med, 2022, 23(1): 37-43. DOI: 10.16506/j.1009-6639.2022.01.007. [21] 吕健, 吴巨龙, 刘倜, 等. 2019-2020流感监测年度山东省B-Victoria系流感病毒基因特征[J]. 中华疾病控制杂志, 2022, 26(3): 367-372. DOI: 10.16462/j.cnki.zhjbkz.2022.03.022.Lyu J, Wu JL, Liu T, et al. Analysis of genetic characteristics of B-Victoria strains of influenza virus in Shandong Province during the influenza surveillance year from 2019 to 2020[J]. Chin J Dis Control Prev, 2022, 26(3): 367-372. DOI: 10.16462/j.cnki.zhjbkz.2022.03.022. [22] 赵文君. 四价流感疫苗在我国首次获批上市[J]. 科技传播, 2018, 10(12): 9. DOI: 10.16607/j.cnki.1674-6708.2018.12.004.Zhao WJ. Tetravalent influenza vaccine was approved for the first time in China[J]. Public Commun Sci Technol, 2018, 10(12): 9. DOI: 10.16607/j.cnki.1674-6708.2018.12.004.